Perioperative beta-blocker use and survival in lung cancer patients

Journal of Clinical Anesthesia

Volumn 26, Issue 2, 2014, Pages 106-117

  Cata, Juan P ^a   Villarreal, John ^a   Keerty, Dinesh ^b   Thakar, Dilip R ^a   Liu, Diane D ^a   Sood, Anil K ^a   Gottumukkala, Vijaya ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Wright Center for Graduate Medical Education   (United States)

Author keywords

Beta blockers; Non small cell lung cancer; Overall survival; Recurrence free survival

Indexed keywords

ANTINEOPLASTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; LABETALOL; METOPROLOL; NADOLOL; PROPRANOLOL;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERTENSION; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SURGICAL STRESS; THORACOTOMY; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84899099401     PISSN: 09528180     EISSN: 18734529     Source Type: Journal    
DOI: 10.1016/j.jclinane.2013.10.004     Document Type: Article

References (26)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. R. Siegel, C. DeSantis, and K. Virgo et al. Cancer treatment and survivorship statistics, 2012 CA Cancer J Clin 62 2012 220 241
3. M. Yokoyama, Y. Itano, and H. Katayama et al. The effects of continuous epidural anesthesia and analgesia on stress response and immune function in patients undergoing radical esophagectomy Anesth Analg 101 2005 1521 1527
4. Z. Cserép, E. Losoncz, and P. Balog et al. The impact of preoperative anxiety and education level on long-term mortality after cardiac surgery J Cardiothorac Surg 7 2012 86
5. P. Mavridou, V. Dimitriou, A. Manataki, E. Arnaoutoglou, and G. Papadopoulos Patient's anxiety and fear of anesthesia: effect of gender, age, education, and previous experience of anesthesia. A survey of 400 patients J Anesth 27 2013 104 108
6. A.K. Sood, R. Bhatty, and A.A. Kamat et al. Stress hormone-mediated invasion of ovarian cancer cells Clin Cancer Res 12 2006 369 375
7. E.K. Sloan, S.J. Priceman, and B.F. Cox et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer Cancer Res 70 2010 7042 7052
8. K. Masur, B. Niggemann, K.S. Zanker, and F. Entschladen Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers Cancer Res 61 2001 2866 2869
9. H.M. Schuller, and B. Cole Regulation of cell proliferation by beta-adrenergic receptors in a human lung adenocarcinoma cell line Carcinogenesis 10 1989 1753 1755
10. P.G. Park, J. Merryman, M. Orloff, and H.M. Schuller Beta-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease Cancer Res 55 1995 3504 3508
11. S. Ben-Eliyahu, G. Shakhar, G.G. Page, V. Stefanski, and K. Shakhar Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors Neuroimmunomodulation 8 2000 154 164
12. M. Benish, I. Bartal, and Y. Goldfarb et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis Ann Surg Oncol 15 2008 2042 2052
13. Y. Goldfarb, L. Sorski, M. Benish, B. Levi, R. Melamed, and S. Ben-Eliyahu Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses Ann Surg 253 2011 798 810
14. A. Glasner, R. Avraham, and E. Rosenne et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor J Immunol 184 2010 2449 2457
15. D.G. Powe, M.J. Voss, and K.S. Zänker et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival Oncotarget 1 2010 628 638
16. A. Melhem-Bertrandt, M. Chavez-Macgregor, and X. Lei et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer J Clin Oncol 29 2011 2645 2652
17. P.A. Ganz, L.A. Habel, E.K. Weltzien, B.J. Caan, and S.W. Cole Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort Breast Cancer Res Treat 129 2011 549 556
18. T.I. Barron, R.M. Connolly, L. Sharp, K. Bennett, and K. Visvanathan Beta blockers and breast cancer mortality: a population-based study J Clin Oncol 29 2011 2635 2644
19. J.G. Baker The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors Br J Pharmacol 144 2005 317 322
20. D. Zhang, Q. Ma, S. Shen, and H. Hu Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell Pancreas 38 2009 94 100
21. X. Liao, X. Che, W. Zhao, D. Zhang, T. Bi, and G. Wang The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling Oncol Rep 24 2010 1669 1676
22. H.A. Al-Wadei, M.H. Al-Wadei, and H.M. Schuller Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention PLoS One 7 2012 e29915
23. H.M. Schuller, and M. Cekanova NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways Lung Cancer 49 2005 35 45
24. P. Volpino, R. Cangemi, and E. Fiori et al. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer J Cardiovasc Surg 48 2007 375 383
25. K.L. Chaichana, A.N. Halthore, and S.L. Parker et al. Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection Clinical article. J Neurosurg 114 2011 604 612
26. J. Concato, A.R. Feinstein, and T.R. Holford The risk of determining risk with multivariable models Ann Intern Med 118 1993 201 210